GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » Gross Profit

Cantourage Group SE (XTER:HIGH) Gross Profit : €1.20 Mil (TTM As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cantourage Group SE Gross Profit?

Cantourage Group SE's gross profit for the six months ended in Jun. 2023 was €0.60 Mil. Cantourage Group SE's gross profit for the trailing twelve months (TTM) ended in Jun. 2023 was €1.20 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Cantourage Group SE's gross profit for the six months ended in Jun. 2023 was €0.60 Mil. Cantourage Group SE's Revenue for the six months ended in Jun. 2023 was €0.60 Mil. Therefore, Cantourage Group SE's Gross Margin % for the quarter that ended in Jun. 2023 was N/A%.

Cantourage Group SE had a gross margin of N/A% for the quarter that ended in Jun. 2023 => No sustainable competitive advantage

During the past 4 years, the highest Gross Margin % of Cantourage Group SE was 35.14%. The lowest was 19.06%. And the median was 27.10%.


Cantourage Group SE Gross Profit Historical Data

The historical data trend for Cantourage Group SE's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantourage Group SE Gross Profit Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Gross Profit
- 0.10 1.83 0.60

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23
Gross Profit Get a 7-Day Free Trial - - - 0.60 0.60

Competitive Comparison of Cantourage Group SE's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantourage Group SE's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's Gross Profit distribution charts can be found below:

* The bar in red indicates where Cantourage Group SE's Gross Profit falls into.



Cantourage Group SE Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Cantourage Group SE's Gross Profit for the fiscal year that ended in Dec. 2022 is calculated as

Gross Profit (A: Dec. 2022 )=Revenue - Cost of Goods Sold
=0.603 - 0
=0.60

Cantourage Group SE's Gross Profit for the quarter that ended in Jun. 2023 is calculated as

Gross Profit (Q: Jun. 2023 )=Revenue - Cost of Goods Sold
=0.599 - 0
=0.60

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1.20 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Cantourage Group SE's Gross Margin % for the quarter that ended in Jun. 2023 is calculated as

Gross Margin % (Q: Jun. 2023 )=Gross Profit (Q: Jun. 2023 ) / Revenue (Q: Jun. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.60 / 0.599
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Cantourage Group SE  (XTER:HIGH) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Cantourage Group SE had a gross margin of N/A% for the quarter that ended in Jun. 2023 => No sustainable competitive advantage


Cantourage Group SE Gross Profit Related Terms

Thank you for viewing the detailed overview of Cantourage Group SE's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantourage Group SE (XTER:HIGH) Business Description

Comparable Companies
Traded in Other Exchanges
Address
Feurigstrasse 54, Berlin, DEU, 10827
Cantourage Group SE is a medical cannabis company. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol, and pharma-grade Cannabidiol.
Executives
Patrick Hoffmann Supervisory Board
Dr. Florian Kainzinger Supervisory Board
Dr. / Dr. Florian / Michael Kainzinger / Ruoff Supervisory Board
Dr. / Dr. Florian /michael Kainzinger / Ruoff Supervisory Board
Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Supervisory Board
Dr. Florian Holzapfel Supervisory Board
Dr. Michael Ruoff Supervisory Board

Cantourage Group SE (XTER:HIGH) Headlines